Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Ross Todd | May 31, 2024
Defense lawyers for GSK, led by Tarek Ismail of Goldman Ismail, and Boehringer Ingelheim, led by Andrew Bayman of King & Spalding, won a defense verdict from state court jurors who rejected a claim that the discontinued heartburn drug Zantac caused an Illinois woman's colon cancer.
7 minute read
By Charles Toutant | May 30, 2024
Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.
4 minute read
By Marianna Wharry | May 28, 2024
Pfizer recently filed seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used to prevent and treat migraines.
2 minute read
By Brian Lee | May 24, 2024
While the Opioid Stewardship Act was upheld, payments made before the law became effective had to be returned.
4 minute read
By Amanda Bronstad | May 23, 2024
An Illinois jury sided with pharmaceutical manufacturers GlaxoSmithKline and Boehringer Ingelheim in the first verdict in the Zantac litigation.
3 minute read
By Allison Dunn | May 22, 2024
"Bayer is pleased with the plaintiff's decision to voluntarily dismiss these meritless claims against the Company in Sidhu and believes that the replicated claims raised in the Copeland filing are equally baseless," the company said in a statement. "The Company continues to stand behind the safety of the product that is supported by extensive scientific evidence."
5 minute read
By Emily Cousins | May 22, 2024
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
3 minute read
By Colleen Murphy | May 21, 2024
"Now, Henrietta Lacks' grandson, Ron Lacks, says Ultragenyx unjustly reaps some of the benefits of the wrongs against his grandmother," District Judge Deborah L. Boardman said. "Ultragenyx says it has done nothing wrong, and Lacks has no viable claim against it. Today, the court reaches one modest conclusion about this dispute: If what Lacks alleges is true, it is plausible that Ultragenyx is liable to Lacks for unjust enrichment."
5 minute read
By Chris O'Malley | May 17, 2024
"I think the industry would like more clarity from the FDA on what exactly its position is on its authority over social media," said Mahnu Davar, a partner at Arnold & Porter Kaye Scholer.
7 minute read
By Charles Toutant | May 13, 2024
ZHP sought to invoke the Apex Doctrine, which seeks to limit depositions of individuals at the "apex" of a corporation based on the premise that lower-level employees are likely to have firsthand knowledge of the material facts, and that deposing the top executives of a corporation is likely to impose a significant burden.
5 minute read
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS